Pharmacological treatment for overactive bladder in women

被引：0
作者：
Robinson, Dudley [1 ]
Cardozo, Linda [1 ]
机构：
[1] Kings Coll Hosp London, Dept Urogynaecol, Denmark Hill, London, England
来源：
WOMENS HEALTH | 2006年 / 2卷 / 02期
关键词：
antimuscarinics; detrusor overactivity; overactive bladder; urinary incontinence;
D O I：
10.2217/17455057.2.2.239
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Urinary incontinence is a common and distressing condition that is known to adversely affect quality of life. Overactive bladder is the term used to describe the symptom complex of urinary frequency and urgency, with or without urge incontinence. Drug therapy, in addition to behavioral modification, remains integral in the management of women with overactive bladder, and the development of new drugs, treatment regimens and methods of delivery should improve patient compliance and acceptability. This article critically reviews the current pharmacological treatment of overactive bladder in addition to providing a rationale for treatment.
引用
收藏
页码：239 / 250
页数：12
相关论文
共 94 条
[91]   Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder [J].
Van Kerrebroeck, P ;
Kreder, K ;
Jonas, U ;
Zinner, N ;
Wein, AN .
UROLOGY, 2001, 57 (03) :414-421
[92]   Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland [J].
Waldeck, K ;
Larsson, B ;
Andersson, KE .
JOURNAL OF UROLOGY, 1997, 157 (03) :1093-1097
[93]   INTRAVESICAL OXYBUTYNIN CHLORIDE - EXPERIENCE WITH 42 PATIENTS [J].
WEESE, DL ;
ROSKAMP, DA ;
LEACH, GE ;
ZIMMERN, PE .
UROLOGY, 1993, 41 (06) :527-530
[94]   Evaluation of mRNAs encoding muscarinic receptor subtypes in human detrusor muscle [J].
Yamaguchi, O ;
Shishido, K ;
Tamura, K ;
Ogawa, T ;
Fujimura, T ;
Ohtsuka, M .
JOURNAL OF UROLOGY, 1996, 156 (03) :1208-1213
12345678910